Literature DB >> 27347446

Uveitic Macular Edema: Treatment Update.

Raquel Goldhardt1, Bradley Simon Rosen2.   

Abstract

The aim of this review is to summarize recent developments in the treatment of uveitic macular edema (ME). ME represent a major cause of visual loss in uveitis and adequate management is crucial for the maintenance of useful vision in patients with chronic uveitis.

Entities:  

Keywords:  Uveitic macula edema; corticosteroids; immunosuppressive therapy; inflammation; inflammatory edema; uveitis

Year:  2016        PMID： 27347446      PMCID： PMC4917282          DOI： 10.1007/s40135-016-0090-3

Source DB:  PubMed          Journal:  Curr Ophthalmol Rep        ISSN： 2167-4868


  76 in total

Review 1.  Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

Authors:  D A Jabs; J T Rosenbaum; C S Foster; G N Holland; G J Jaffe; J S Louie; R B Nussenblatt; E R Stiehm; H Tessler; R N Van Gelder; S M Whitcup; D Yocum
Journal:  Am J Ophthalmol       Date:  2000-10       Impact factor: 5.258

2.  Smoking as a risk factor for cystoid macular edema complicating intermediate uveitis.

Authors:  Jennifer E Thorne; Ebenezer Daniel; Douglas A Jabs; Sanjay R Kedhar; George B Peters; James P Dunn
Journal:  Am J Ophthalmol       Date:  2008-03-05       Impact factor: 5.258

3.  Impact of macular edema on visual acuity in uveitis.

Authors:  Charlotte W T A Lardenoye; Bram van Kooij; Aniki Rothova
Journal:  Ophthalmology       Date:  2006-08       Impact factor: 12.079

Review 4.  Understanding uveitis: the impact of research on visual outcomes.

Authors:  Marc D de Smet; Simon R J Taylor; Bahram Bodaghi; Elisabetta Miserocchi; Philip I Murray; Uwe Pleyer; Manfred Zierhut; Talin Barisani-Asenbauer; Phuc LeHoang; Sue Lightman
Journal:  Prog Retin Eye Res       Date:  2011-07-22       Impact factor: 21.198

5.  Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema.

Authors:  Baruch D Kuppermann; Mark S Blumenkranz; Julia A Haller; George A Williams; David V Weinberg; Connie Chou; Scott M Whitcup
Journal:  Arch Ophthalmol       Date:  2007-03

6.  Vitamin E in the treatment of uveitis-associated macular edema.

Authors:  Robert B Nussenblatt; Jonghyeon Kim; Darby J S Thompson; Matthew D Davis; Emily Chew; Frederick L Ferris; Ronald Buggage
Journal:  Am J Ophthalmol       Date:  2006-01       Impact factor: 5.258

7.  Adalimumab therapy for refractory uveitis: a pilot study.

Authors:  Manuel Diaz-Llopis; Salvador García-Delpech; David Salom; Patricia Udaondo; Marisa Hernández-Garfella; Francisco Bosch-Morell; Arturo Quijada; Francisco J Romero
Journal:  J Ocul Pharmacol Ther       Date:  2008-06       Impact factor: 2.671

8.  Intravitreal bevacizumab for treatment of uveitic macular edema.

Authors:  Miguel Cordero Coma; Lucia Sobrin; Sumru Onal; William Christen; C Stephen Foster
Journal:  Ophthalmology       Date:  2007-03-23       Impact factor: 12.079

9.  Comparison of the efficacy and safety of different methods of posterior subtenon injection.

Authors:  Pradeep Venkatesh; Chandra Shekhar Kumar; Zahir Abbas; Satpal Garg
Journal:  Ocul Immunol Inflamm       Date:  2008 Sep-Oct       Impact factor: 3.070

10.  Intravitreal bevacizumab (avastin) as a treatment for refractory macular edema in patients with uveitis: a pilot study.

Authors:  Friederike Mackensen; Carsten Heinz; Matthias D Becker; Arnd Heiligenhaus
Journal:  Retina       Date:  2008-01       Impact factor: 4.256
View more
  7 in total

1.  [Intravitreal methotrexate for treatment of uveitic cystoid macular edema].

Authors:  J Maaß; E Matthé
Journal:  Ophthalmologe       Date:  2018-07       Impact factor: 1.059

2.  Systemic contribution of inflammatory mediators to the severity of diabetic and uveitic macular edema.

Authors:  Marc Figueras-Roca; Jessica Matas; Víctor Llorens; Anna Sala-Puigdollers; Manuel Navarro; Javier Zarranz-Ventura; Alfredo Adán; Blanca Molins
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-03-12       Impact factor: 3.117

3.  New Drugs and New Posterior Delivery Methods in CME.

Authors:  João Rafael de Oliveira Dias; Renata Portella Nunes; Raquel Goldhardt
Journal:  Curr Ophthalmol Rep       Date:  2017-04-07

Review 4.  Clinical Features and Treatments of Syphilitic Uveitis: A Systematic Review and Meta-Analysis.

Authors:  Ting Zhang; Ying Zhu; Gezhi Xu
Journal:  J Ophthalmol       Date:  2017-06-29       Impact factor: 1.909

Review 5.  Intravitreal Dexamethasone Implant in the Treatment of Non-Infectious Uveitic Macular Edema.

Authors:  Omer Karti; Ali Osman Saatci
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2018

6.  New insights into cataract surgery in patients with uveitis: A detailed review of the current literature.

Authors:  Rakan S Al-Essa; Abdullah M Alfawaz
Journal:  Saudi J Ophthalmol       Date:  2022-02-18

7.  Modelling Macular Edema: The Effect of IL-6 and IL-6R Blockade on Human Blood-Retinal Barrier Integrity In Vitro.

Authors:  Marina Mesquida; Faye Drawnel; Philippa J Lait; David A Copland; Madeleine L Stimpson; Victor Llorenç; Maite Sainz de la Maza; Alfredo Adan; Gabriella Widmer; Pamela Strassburger; Sascha Fauser; Andrew D Dick; Richard W J Lee; Blanca Molins
Journal:  Transl Vis Sci Technol       Date:  2019-10-28       Impact factor: 3.283
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.